The Paradoxical Effect of Cannabis Use on Cognition in Chronic Psychotic Disorders
Fiorela Gorea, Martina Pelle, Federico Fiori Nastro, Carmine Gelormini, Fatime Elezi, Michele Ribolsi, Giorgio Di Lorenzo
Pathophysiology January 27, 2026 DOI: 10.3390/pathophysiology33010011 (opens in new tab)
Summary
AI-generated from the abstractIn a cohort of 105 inpatients with psychotic disorders in Tirana, cannabis users were more often male, younger, and had earlier psychosis onset than non-users. Cannabis users scored higher on the Montreal Cognitive Assessment, with the best scores among daily users. The authors suggest that, contrary to common assumptions, cannabis use may be associated with preserved cognitive functioning in psychosis, but they emphasize the need to consider dosage, frequency, and THC/CBD ratio when interpreting these outcomes.
Study at a glance
| Characteristics | Observational cohort Peer reviewed |
|---|---|
| Sample size | 105 |
| Population | Inpatients with psychotic disorders |
| Key finding | Cannabis users with psychotic disorders scored higher on the Montreal Cognitive Assessment than non-users, with the highest scores among daily users. |
Abstract
Background/Objectives: Cannabis use has a particularly high prevalence in individuals with psychotic disorders. Although cannabis use is generally associated with cognitive impairments in the general population, its impact on cognition in psychosis remains controversial. This study aimed to investigate the association between cannabis use and cognitive performance in a cohort of individuals affected by psychotic disorders. Methods: A total of 105 inpatients with psychotic disorders (mean age: 40.3 years; 34 females) were recruited from the University Hospital Center “Mother Teresa” in Tirana. Data collection included socio-demographic and clinical variables. Cognitive functioning was evaluated using the Montreal Cognitive Assessment (MoCA), while psychopathology was assessed with the Brief Negative Symptom Scale (BNSS), the Calgary Depression Scale for Schizophrenia (CDSS), the Psychotic Symptom Rating Scales (PSYRATS), and the Scale for the Assessment of Thought, Language, and Communication (TLC). Results: Cannabis users (CU) were more frequently male, younger, and exhibited an earlier onset of psychosis compared to non-users (No-CU). Importantly, CU demonstrated higher MoCA scores, with the most favorable outcomes observed among daily users. Conclusions: Contrary to the prevailing assumption that cannabis use exacerbates cognitive decline, our findings indicate an unexpected association between cannabis use and preserved cognitive functioning in psychosis. These results underscore the need to consider dosage, frequency, and cannabinoid composition (THC/CBD ratio) when interpreting cannabis-related cognitive outcomes in psychotic disorders.